Stevanato Group S.p.A (STVN) Cash from Financing Activities (2020 - 2026)
Stevanato Group S.p.A's (STVN) quarterly Cash from Financing Activities came in at -$29.2 million in Q1 2026, up 22.37% year-on-year from -$23.8 million in Q1 2025, and down 245.6% on a QoQ basis from $20.0 million in Q4 2025.
Stevanato Group S.p.A (STVN) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Cash from Financing Activities data on file, last reported at -$29.2 million in Q1 2026.
- On a quarterly basis, Cash from Financing Activities rose 22.37% year-over-year to -$29.2 million in Q1 2026; TTM through Mar 2026 was $37.5 million, a 2223.28% increase from a year earlier, with the FY2025 full-year figure at $25.7 million, down 86.86% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$29.2 million, down from $20.0 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for STVN reached as high as $159.6 million in Q1 2024 and fell as low as -$64.0 million in Q2 2024.
- Historically, Cash from Financing Activities has averaged $19.0 million across 5 years, with a median of $8.6 million in 2023.
- Across the five-year window, Cash from Financing Activities jumped 1758.52% in 2024 and slumped 123.53% in 2025, its largest moves.
- Year by year, Cash from Financing Activities stood at -$19.0 million in 2022, then surged by 597.24% to $94.4 million in 2023, then decreased by 24.92% to $70.8 million in 2024, then tumbled by 71.74% to $20.0 million in 2025, then tumbled by 245.6% to -$29.2 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$29.2 million in Q1 2026, $20.0 million in Q4 2025, and $22.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Stevanato Group S.p.A | 5.29 Bn | 5.15 Bn | 88.01 Mn | -29.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.15 Mn |
| Mar 31, 2026 | -29.15 Mn |
| Dec 31, 2025 | 20.02 Mn |
| Dec 31, 2025 | 20.02 Mn |
| Sep 30, 2025 | 22.68 Mn |
| Sep 30, 2025 | 22.68 Mn |
| Jun 30, 2025 | 24.00 Mn |
| Jun 30, 2025 | 24.00 Mn |
| Mar 31, 2025 | -37.55 Mn |
| Mar 31, 2025 | -37.55 Mn |
| Dec 31, 2024 | 70.85 Mn |
| Dec 31, 2024 | 70.85 Mn |
| Sep 30, 2024 | 32.29 Mn |
| Sep 30, 2024 | 32.29 Mn |
| Jun 30, 2024 | -63.97 Mn |
| Jun 30, 2024 | -63.97 Mn |
| Mar 31, 2024 | 159.59 Mn |
| Mar 31, 2024 | 159.59 Mn |
| Dec 31, 2023 | 94.36 Mn |
| Dec 31, 2023 | 94.36 Mn |